Article Details

Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line ...

Retrieved on: 2021-02-02 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line .... View article details on hiswai:

Excerpt

For the enhancement of such antibody's ADCC, ProBioGen will apply its ... both fully human monoclonal antibodies and heavy chain only antibodies ...

Article found on: www.b3cnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo